Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab‐based model

Anahita Rabiee(Yale University), Guadalupe García–Tsao(Connecticut Health Foundation), Yanhong Deng(Sun Yat-sen University), Joan Genescà(Universitat Autònoma de Barcelona), Maria Ciarleglio(Yale University), Mònica Pons(Universitat Autònoma de Barcelona), Jean L. Chan(Hadassah Medical Center)

Hepatology Communications

October 10, 2022

10.1002/hep4.2091

Cited by 48

Related Papers

Recombinant Human Leptin in Women with Hypothalamic Amenorrhea

|New England Journal of Medicine|2004|916

Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites

|Journal of Hepatology|2015|864

Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

|Hepatology|2021|794

Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites

|Gut|2015|576

The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men

|Journal of Clinical Investigation|2003|575